CanSino Biologics Balance Sheet Health
Financial Health criteria checks 4/6
CanSino Biologics has a total shareholder equity of CN¥5.1B and total debt of CN¥2.4B, which brings its debt-to-equity ratio to 47.5%. Its total assets and total liabilities are CN¥8.6B and CN¥3.5B respectively.
Key information
47.5%
Debt to equity ratio
CN¥2.43b
Debt
Interest coverage ratio | n/a |
Cash | CN¥4.01b |
Equity | CN¥5.11b |
Total liabilities | CN¥3.46b |
Total assets | CN¥8.57b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CJH's short term assets (CN¥5.0B) exceed its short term liabilities (CN¥2.1B).
Long Term Liabilities: CJH's short term assets (CN¥5.0B) exceed its long term liabilities (CN¥1.4B).
Debt to Equity History and Analysis
Debt Level: CJH has more cash than its total debt.
Reducing Debt: CJH's debt to equity ratio has increased from 29.9% to 47.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CJH has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if CJH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.